Cargando…
Economic Burden of Growth Hormone Deficiency in a US Pediatric Population
Pediatric GHD is a rare disorder of short stature that is currently treated with daily injections of GH. In addition to short stature, GHD is associated with other comorbidities such as impaired musculoskeletal development, cardiovascular disease, and decreased quality of life. The objective of this...
Autores principales: | Kaplowitz, Paul B, Manjelievskaia, Janna, Lopez-Gonzalez, Lorena, Marrow, Cynthia D, Pitukcheewanont, Pisit, Smith, Alden |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090744/ http://dx.doi.org/10.1210/jendso/bvab048.1376 |
Ejemplares similares
-
Economic burden of growth hormone deficiency in a US pediatric population
por: Kaplowitz, Paul, et al.
Publicado: (2021) -
PMON64 Economic Burden of Growth Hormone Deficiency in a US Adult Population
por: Smith, Alden, et al.
Publicado: (2022) -
SUN-248 Growth Hormone Deficiency (GHD): Assessing Burden of Treatment in Children and Adolescents
por: Brod, Meryl, et al.
Publicado: (2019) -
Racial/Ethnic Disparities in the Investigation and Treatment of Pediatric Growth Hormone Deficiency
por: Hawkes, Colin Patrick, et al.
Publicado: (2021) -
OR10-06 Somatrogon Growth Hormone in the Treatment of Pediatric Growth Hormone Deficiency: Results of the Pivotal Pediatric Phase 3 Clinical Trial
por: Deal, Cheri L, et al.
Publicado: (2020)